![]() |
|
|
German Institute of Human Nutrition, Department of Gastrointestinal Microbiology, 14558 Potsdam-Rehbrücke, Germany
1To whom correspondence should be addressed.
The anticarcinogen conjugated linoleic acid (CLA) is a product of
bacterial activity that isomerizes linoleic acid (LA) in the rumen of
herbivores. Therefore, fatty dairy products in the human diet are
enriched with CLA. Although bacteria capable of in vitro LA conjugation
were detected in the human intestinal tract, CLA synthesis from dietary
sunflower seed oil was not observed in gnotobiotic rats associated with
these intestinal bacteria. The objective of the study was to
investigate variables that affect LA conjugation. In vitro, LA
conjugation was strongly inhibited by glucose and other substrates.
Concentrations of 1.5 mmol glucose/L inhibited LA conjugation by 50%.
Methyl-
-D-glucoside was a less effective inhibitor than
glucose, and 2-deoxy-D-glucose did not inhibit LA
conjugation at all. To analyze the concentration of carbohydrates in
intestinal contents, the LA-conjugating bacterial mixed culture and
human fecal microorganisms were introduced into germ-free rats.
Samples of feces and cecum and colon contents of both groups exhibited
in vitro LA-conjugating activity. Rats associated with human
intestinal microorganisms contained 5.7 ± 1.3 mmol glucose/L in
the cecal contents and 6.6 ± 1.0 mmol glucose/L in the colonic
contents. Rats associated with CLA-producing bacterial culture
contained 3.4 ± 1.3 mmol glucose/L in the cecal contents and 4.2
± 1.0 mmol glucose/L in the colonic contents. These values are
within a range that may explain the observed inhibition of LA
conjugation in vivo.
KEY WORDS: conjugated linoleic acid gnotobiotic rats glucose inhibition intestinal microorganisms
This article has been cited by other articles:
![]() |
E. Devillard, F. M. McIntosh, D. Paillard, N. A. Thomas, K. J. Shingfield, and R. J. Wallace Differences between human subjects in the composition of the faecal bacterial community and faecal metabolism of linoleic acid Microbiology, February 1, 2009; 155(2): 513 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. McIntosh, K. J. Shingfield, E. Devillard, W. R. Russell, and R. J. Wallace Mechanism of conjugated linoleic acid and vaccenic acid formation in human faecal suspensions and pure cultures of intestinal bacteria Microbiology, January 1, 2009; 155(1): 285 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Alibin, M. A. Kopilas, and H. D. I. Anderson Suppression of Cardiac Myocyte Hypertrophy by Conjugated Linoleic Acid: ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS {alpha} AND {gamma} J. Biol. Chem., April 18, 2008; 283(16): 10707 - 10715. [Abstract] [Full Text] [PDF] |
||||